Over the past decades, transcatheter therapy has become the primary option for the
treatment of simple congenital heart diseases with the advantages of minimal invasiveness …

Ventricular septal defect (VSD) is one of the most common congenital cardiac malformations
and 60–80% of VSDs are categorized as perimembranous VSDs. Approximately half of the …

Please note: This study was sponsored by Edwards Lifesciences. Dr. Barker has served on
advisory boards for Medtronic and Boston Scientific; and has been a consultant to Edwards …

Ventricular septal defects (VSDs) are among the most common congenital heart defects,
with an incidence rate of 3 to 3.5 per 1000 live births. 1 VSDs range in size from tiny …

Cardiac septal defect is the most prevalent congenital heart disease and is typically treated
with open‐heart surgery under cardiopulmonary bypass. Since the 1990s, with the …

Introduction Ventricular septal defect (VSD) is the most common (approximately 20%)
congenital heart disease. 1 About 70% of these defects are perimembranous (PmVSD) …

The name Patrick Serruys is synonymous with stenting and interventional cardiology, which
he has been involved with since its inception. He was the first-ever chair of interventional …

Transcatheter closure of atrial septal defects has been employed increasingly in the past
decade. This technique is now regarded as the treatment of choice for patients with …

There are three major classes of cardiovascular implants that can benefit from
biodegradable materials: coronary/peripheral stents, occluders for heart defects, and …

To date, there has been limited investigation of bioabsorbable atrial septal defect (ASD) or
patent foramen ovale (PFO) closure devices using clinically relevant large animal models …